1. |
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin, 2019, 69(1): 7-34.
|
2. |
Gu J, Chen N. Current status of rectal cancer treatment in China. Colorectal Dis, 2013, 15(11): 1345-1350.
|
3. |
Feng RM, Zong YN, Cao SM, et al. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics? Cancer Commun (Lond), 2019, 39(1): 22.
|
4. |
Petrillo M, Fusco R, Catalano O, et al. MRI for assessing response to neoadjuvant therapy in locally advanced rectal cancer using DCE-MR and DW-MR data sets: a preliminary report. Biomed Res Int, 2015, 2015: 514740.
|
5. |
Battersby NJ, How P, Moran B, et al. Prospective validation of a low rectal cancer magnetic resonance imaging staging system and development of a local recurrence risk stratification model: The Mercury Ⅱ Study. Ann Surg, 2016, 263(4): 751-760.
|
6. |
Beets-Tan RG, Lambregts DM, Maas M, et al. Magnetic resonance imaging for the clinical management of rectal cancer patients: recommendations from the 2012 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur Radiol, 2013, 23(9): 2522-2531.
|
7. |
Gollub MJ, Maas M, Weiser M, et al. Recognition of the anterior peritoneal reflection at rectal MRI. AJR Am J Roentgenol, 2013, 200(1): 97-101.
|
8. |
Nougaret S, Reinhold C, Mikhael HW, et al. The use of MR imaging in treatment planning for patients with rectal carcinoma: have you checked the " DISTANCE”? Radiology, 2013, 268(2): 330-344.
|
9. |
Roodbeen SX, Penna M, Mackenzie H, et al. Transanal total mesorectal excision (TaTME) versus laparoscopic TME for MRI-defined low rectal cancer: a propensity score-matched analysis of oncological outcomes. Surg Endosc, 2019, 33(8): 2459-2467.
|
10. |
Cattapan K, Chulroek T, Wancharoenrung D, et al. Can MR imaging be useful in differentiating low rectal cancer from anal cancer? Abdom Radiol (NY), 2019, 44(2): 438-445.
|
11. |
Tong GJ, Zhang GY, Liu J, et al. Comparison of the eighth version of the American Joint Committee on Cancer manual to the seventh version for colorectal cancer: A retrospective review of our data. World J Clin Oncol, 2018, 9(7): 148-161.
|
12. |
Li F, Zhang W, Li J, et al. The clinical application value of MR diffusion-weighted imaging in the diagnosis of rectal cancer: A retrospective study. Medicine (Baltimore), 2018, 97(51): e13732.
|
13. |
Çolakoğlu Er H, Peker E, Erden A, et al. Rectal cancer confined to the bowel wall: the role of 3 Tesla phased-array MR imaging in T categorization. Br J Radiol, 2018, 91(1082): 20170581.
|
14. |
Maas M, Lambregts DM, Lahaye MJ, et al. T-staging of rectal cancer: accuracy of 3.0 Tesla MRI compared with 1.5 Tesla. Abdom Imaging, 2012, 37(3): 475-481.
|
15. |
Nicholls RJ, Zinicola R, Haboubi N. Extramural spread of rectal cancer and the AJCC Cancer Staging Manual 8th Edition, 2017. Ann Oncol, 2019 May 2. pii: mdz147. doi: 10.1093/annonc/mdz147.
|
16. |
Zinicola R, Pedrazzi G, Haboubi N, et al. The degree of extramural spread of T3 rectal cancer: an appeal to the American Joint Committee on Cancer. Colorectal Dis, 2017, 19(1): 8-15.
|
17. |
Nougaret S, Jhaveri K, Kassam Z, et al. Rectal cancer MR staging: pearls and pitfalls at baseline examination. Abdom Radiol (NY), 2019 May 21. doi: 10.1007/s00261-019-02024-0.
|
18. |
Tong T, Yao Z, Xu L, et al. Extramural depth of tumor invasion at thin-section MR in rectal cancer: associating with prognostic factors and ADC value. J Magn Reson Imaging, 2014, 40(3): 738-744.
|
19. |
Pedersen BG, Moran B, Brown G, et al. Reproducibility of depth of extramural tumor spread and distance to circumferential resection margin at rectal MRI: enhancement of clinical guidelines for neoadjuvant therapy. AJR Am J Roentgenol, 2011, 197(6): 1360-1366.
|
20. |
Gröne J, Loch FN, Taupitz M, et al. Accuracy of various lymph node staging criteria in rectal cancer with magnetic resonance imaging. J Gastrointest Surg, 2018, 22(1): 146-153.
|
21. |
Mizukami Y, Ueda S, Mizumoto A, et al. Diffusion-weighted magnetic resonance imaging for detecting lymph node metastasis of rectal cancer. World J Surg, 2011, 35(4): 895-899.
|
22. |
Attenberger UI, Pilz LR, Morelli JN, et al. Multi-parametric MRI of rectal cancer—do quantitative functional MR measurements correlate with radiologic and pathologic tumor stages? Eur J Radiol, 2014, 83(7): 1036-1043.
|
23. |
Heijnen LA, Lambregts DM, Mondal D, et al. Diffusion-weighted MR imaging in primary rectal cancer staging demonstrates but does not characterise lymph nodes. Eur Radiol, 2013, 23(12): 3354-3360.
|
24. |
Seber T, Caglar E, Uylar T, et al. Diagnostic value of diffusion-weighted magnetic resonance imaging: differentiation of benign and malignant lymph nodes in different regions of the body. Clin Imaging, 2015, 39(5): 856-862.
|
25. |
Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging, 1999, 10(3): 223-232.
|
26. |
Armbruster M, D'Anastasi M, Holzner V, et al. Improved detection of a tumorous involvement of the mesorectal fascia and locoregional lymph nodes in locally advanced rectal cancer using DCE-MRI. Int J Colorectal Dis, 2018, 33(7): 901-909.
|
27. |
Lahaye MJ, Engelen SM, Kessels AG, et al. USPIO-enhanced MR imaging for nodal staging in patients with primary rectal cancer: predictive criteria. Radiology, 2008, 246(3): 804-811.
|
28. |
Zhang H, Zhang C, Zheng Z, et al. Chemical shift effect predicting lymph node status in rectal cancer using high-resolution MR imaging with node-for-node matched histopathological validation. Eur Radiol, 2017, 27(9): 3845-3855.
|
29. |
Lambregts DM, Heijnen LA, Maas M, et al. Gadofosveset-enhanced MRI for the assessment of rectal cancer lymph nodes: predictive criteria. Abdom Imaging, 2013, 38(4): 720-727.
|
30. |
Ale Ali H, Kirsch R, Razaz S, et al. Extramural venous invasion in rectal cancer: overview of imaging, histopathology, and clinical implications. Abdom Radiol (NY), 2019, 44(1): 1-10.
|
31. |
Jhaveri KS, Hosseini-Nik H, Thipphavong S, et al. MRI detection of extramural venous invasion in rectal cancer: Correlation with histopathology using elastin stain. AJR Am J Roentgenol, 2016, 206(4): 747-755.
|
32. |
Prampolini F, Taschini S, Pecchi A, et al. Magnetic resonance imaging performed before and after preoperative chemo-radiotherapy in rectal cancer: predictive factors of recurrence and prognostic significance of MR-detected extramural venous invasion. Abdom Radiol (NY), 2018 Nov 27. doi: 10.1007/s00261-018-1838-z.
|
33. |
Siddiqui MRS, Simillis C, Hunter C, et al. A meta-analysis comparing the risk of metastases in patients with rectal cancer and MRI-detected extramural vascular invasion (mrEMVI) vs mrEMVI-negative cases. Br J Cancer, 2017, 116(12): 1513-1519.
|
34. |
Kluza E, Kleijnen JP, Martens MH, et al. Non-invasive MR assessment of macroscopic and microscopic vascular abnormalities in the rectal tumour-surrounding mesorectum. Eur Radiol, 2016, 26(5): 1311-1319.
|
35. |
Vliegen RF, Beets GL, Lammering G, et al. Mesorectal fascia invasion after neoadjuvant chemotherapy and radiation therapy for locally advanced rectal cancer: accuracy of MR imaging for prediction. Radiology, 2008, 246(2): 454-462.
|
36. |
Park MJ, Kim SH, Lee SJ, et al. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging for predicting tumor clearance of the mesorectal fascia after neoadjuvant chemotherapy and radiation therapy. Radiology, 2011, 260(3): 771-780.
|
37. |
Kim CH, Yeom SS, Lee SY, et al. Prognostic impact of perineural invasion in rectal cancer after neoadjuvant chemoradiotherapy. World J Surg, 2019, 43(1): 260-272.
|
38. |
Huang Y, He L, Dong D, et al. Individualized prediction of perineural invasion in colorectal cancer: development and validation of a radiomics prediction model. Chin J Cancer Res, 2018, 30(1): 40-50.
|
39. |
Yeo DM, Oh SN, Choi MH, et al. Histogram analysis of perfusion parameters from dynamic contrast-enhanced MR imaging with tumor characteristics and therapeutic response in locally advanced rectal cancer. Biomed Res Int, 2018, 2018: 3724393.
|
40. |
张巍, 黄子星, 张笑, 等. 结直肠癌的放射组学研究进展. 中国普外基础与临床杂志, 2019, 26(4): 484-487.
|
41. |
Granata V, Fusco R, Reginelli A, et al. Diffusion kurtosis imaging in patients with locally advanced rectal cancer: current status and future perspectives. J Int Med Res, 2019, 47(6): 2351-2360.
|
42. |
Yoon J, Chung YE, Lim JS, et al. Quantitative assessment of mesorectal fat: new prognostic biomarker in patients with mid-to-lower rectal cancer. Eur Radiol, 2019, 29(3): 1240-1247.
|